Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart S Hendriks

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Current Opinion in Chemical Biology|July 9, 2010
Functional pathway pharmacology: chemical tools, pathway knowledge and mechanistic model-based interpretation of experimental dataBart S Hendriks
Clinical Pharmacology and Therapeutics|May 10, 2021
Essential (and Largely Untaught) Skills for Clinical Pharmacology in Oncology Drug DevelopmentBart S Hendriks, Karthik Venkatakrishnan
Bioinformatics (Oxford, England)|December 8, 2009
DataPflex: a MATLAB-based tool for the manipulation and visualization of multidimensional datasetsBart S Hendriks, Christopher W Espelin
Biotechnology Progress|October 9, 2007
Analysis of mechanistic pathway models in drug discovery: p38 pathwayBart S Hendriks, Fei Hua, Jeffrey R Chabot
Biophysical Journal|September 26, 2003
HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanismsBart S Hendriks, H Steven Wiley, Douglas Lauffenburger
Cancer Chemotherapy and Pharmacology|November 4, 2020
Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer typesNadia Terranova, Mendel Jansen, Martin Falk, et al.
BMC Systems Biology|March 17, 2010
Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitroBart S Hendriks, Kelly M Seidl, Jeffrey R Chabot
Cancer Research|March 5, 2003
Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effectsBart S Hendriks, Lee K Opresko, H Steven Wiley, et al.
Clinical Pharmacology and Therapeutics|April 20, 2023
Exploratory Food Effect Assessment in Patients in Early Clinical Development of Oncology DrugsYan Ji, Eugene Tan, Thomas Hengelage, et al.
The Journal of Biological Chemistry|April 11, 2003
Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levelsBart S Hendriks, Lee K Opresko, H Steven Wiley, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Opinion in Chemical Biology|July 9, 2010
Functional pathway pharmacology: chemical tools, pathway knowledge and mechanistic model-based interpretation of experimental dataBart S Hendriks
Clinical Pharmacology and Therapeutics|May 10, 2021
Essential (and Largely Untaught) Skills for Clinical Pharmacology in Oncology Drug DevelopmentBart S Hendriks, Karthik Venkatakrishnan
Bioinformatics (Oxford, England)|December 8, 2009
DataPflex: a MATLAB-based tool for the manipulation and visualization of multidimensional datasetsBart S Hendriks, Christopher W Espelin
Biotechnology Progress|October 9, 2007
Analysis of mechanistic pathway models in drug discovery: p38 pathwayBart S Hendriks, Fei Hua, Jeffrey R Chabot
Biophysical Journal|September 26, 2003
HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanismsBart S Hendriks, H Steven Wiley, Douglas Lauffenburger
Cancer Chemotherapy and Pharmacology|November 4, 2020
Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer typesNadia Terranova, Mendel Jansen, Martin Falk, et al.
BMC Systems Biology|March 17, 2010
Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitroBart S Hendriks, Kelly M Seidl, Jeffrey R Chabot
Cancer Research|March 5, 2003
Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effectsBart S Hendriks, Lee K Opresko, H Steven Wiley, et al.
Clinical Pharmacology and Therapeutics|April 20, 2023
Exploratory Food Effect Assessment in Patients in Early Clinical Development of Oncology DrugsYan Ji, Eugene Tan, Thomas Hengelage, et al.
The Journal of Biological Chemistry|April 11, 2003
Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levelsBart S Hendriks, Lee K Opresko, H Steven Wiley, et al.
Pageof 4